Results 141 to 150 of about 78,793 (257)

Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost‐Effectiveness Analysis

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background Baloxavir marboxil, an antiviral used only in private hospitals in Hong Kong since February 2019 for treating influenza, is recognized for its efficacy against strains resistant to standard antiviral agents, providing an alternative to neuraminidase inhibitors such as oseltamivir.
Ruohan Chen, Zengyang Shao, Kaiming Bi, Benjamin John Cowling, Zhanwei Du   +4 more
wiley   +1 more source

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09‐Associated Hospitalizations With SARI in Beijing, China, in the 2024–2025 Season

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background In the 2024–2025 season, influenza activity returned to pre‐COVID‐19 pandemic levels, with A(H1N1)pdm09 as the predominant subtype. Reassessment vaccine effectiveness (VE) in hospitalized patients is critical to inform potential adjustments to vaccination policy.
Chunna Ma, Ying Sun, Jiaxin Ma, Yingying Wang, Xiaodi Hu, Ying Shen, Li Zhang, Jiaojiao Zhang, Lu Zhang, Wei Duan, Jia Li, Quanyi Wang, Daitao Zhang, Peng Yang   +13 more
wiley   +1 more source

Fatal familial insomnia that begins with unconsciousness: A case report

Sleep Research, Volume 3, Issue 1, Page 71-77, March 2026.
Wenyan Liu, Xinyue Xing, Xiaoming Wang, Xuqian Liu, Mingyue Liu, Wei Shang, Zhaohong Xie   +6 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, Volume 74, Issue 3, Page 636-647, March 2026.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

The Association Between Home‐Visit Nursing Use and the Incidence of Potentially Avoidable Hospitalisation and Its Duration Among Community‐Dwelling Older People: A 12‐Month Prospective Cohort Study

International Journal of Older People Nursing, Volume 21, Issue 2, March 2026.
ABSTRACT Background Preventing potentially avoidable hospitalisation (PAH) and reducing its duration are crucial to allow community‐dwelling older people to age at home. In Japan, homecare services, which include a variety of services such as home help, home‐based rehabilitation and home‐visit nursing, are covered by medical and long‐term care ...
Asa Inagaki‐Asano, Chie Fukui, Ayumi Igarashi, Mariko Sakka, Sameh Eltaybani, Maiko Noguchi‐Watanabe, Yoshinori Takeuchi, Noriko Yamamoto‐Mitani   +7 more
wiley   +1 more source

Infectious Bronchitis Virus [PDF]

, 2019
Ding Xiang Liu, Yan Ling Ng, To Sing Fung   +2 more
openaire   +1 more source

Pathogenicity and Bioinformatics Analysis of Two GI-13 Infectious Bronchitis Virus Strains in China. [PDF]

Transbound Emerg Dis
Jin J, Zhao L, Lv Y, Bao E.
europepmc   +1 more source

Genetic Diversity of Infectious Bronchitis Virus Genotype II in Poland. [PDF]

Pathogens
Pikuła A, Lisowska A, Opolska J, Domańska-Blicharz K.   +3 more
europepmc   +1 more source

Research progress and applications of reverse genetics systems for infectious bronchitis virus. [PDF]

Poult Sci
Zhao Y.
europepmc   +1 more source

Construction and Immunogenicity Evaluation of a Recombinant Infectious Bronchitis Virus H120-Based Vaccine in Broiler Chickens. [PDF]

Animals (Basel)
Nayef A, Jibreen S, Ababneh M.
europepmc   +1 more source